Angiopoietins are important growth factors for vascular development and quiescence. They are 2 promising targets for pro-or anti-angiogenic therapies in diverse pathologies, but the mechanisms of 3 the ANGPT/TIE2 system are complex and not well understood. The function of the angiopoietins 4 seems to depend on the specific tissue and on its environment. However, most in vitro experiments 5 with angiopoietins have been performed with human umbilical vein endothelial cells only. 6
Introduction: 19
Angiogenesis, the remodelling and expansion of a pre-existing vascular network is crucial for 20 development. In the adult it is confined to the cyclic ovarium, the mammary gland and to the 21 placenta, but it is activated during wound healing or in diverse pathological situations including 22 tumorigenesis, ischemic disease, chronic inflammation and other cardiovascular diseases [1, 10, 17] . 23
As a consequence, both pro-and anti-angiogenic treatments are promising therapeutic strategies for 24 a range of pathologies. However, the process of angiogenesis is highly complex, and a better 25 knowledge of the molecular mechanisms of angiogenesis will aid the development of future 26 therapies that aim to enhance or inhibit angiogenesis [9] . 27 A range of growth factors have already been described to influence the process of angiogenesis. One 28 of the most important and best known amongst them is the vascular endothelial growth factors 29 (VEGF). VEGF induces capillary sprouting by stimulating endothelial migration and proliferation. Due 30 to its importance in both development and in various pathological situations, VEGF has been 31 extensively studied in the past decades [23] . The angiopoietins are another family of endothelial 32 specific growth factors. Their role during angiogenesis is still elusive, they are expressed in a range of 33 developing and adult tissues [11, 12, 16] , and it is currently hypothesised that the angiopoietins play 34 a major role during the maturation of the vasculature following VEGF induced angiogenesis [2, 25] . 35 Angiopoietin 1 (ANGPT1) and angiopoietin 2 (ANGPT2) are the most common and best described 36 members of the angiopoietin family. These ligands both bind the endothelial specific TIE2 receptor 37
[27]. ANGPT1 is described as a vascular maturation factor; it induces lumen formation and vascular 38 quiescence by activating the TIE2 receptor. ANGPT2 is an antagonist of ANGPT1, as it binds the TIE2 39 receptor with similar affinity as ANGPT1, but it has a weak ability to activate TIE2 [7, 22] . In this way, 40 ANGPT2 induces vascular destabilisation, which can either lead to the onset of angiogenesis or 41 endothelial regression, depending on the presence or absence of VEGF respectively. However, the 42 antagonistic action of ANGPT2 seems to be context and tissue dependent [25] . Recent data indicates 43 that ANGPT-TIE2 activation is regulated by the TIE1 receptor [27] . This TIE1 receptor is another 44 endothelial specific receptor that is structurally highly similar to TIE2, but does not interact directly 45 with the angiopoietins [22] . 46
Most of the current knowledge on how the angiopoietins influence angiogenesis has been deduced 47 from complex in vivo models with loss of function or gain of function mutations. These models are 48 often lethal in the embryonic stage of development and hardly provide the possibility to investigate 49 the mechanism in real time [5] . In vitro models of angiogenesis might provide an alternative, as these 50 experiments are more standardized and can be monitored in real time. Various in vitro models of 51 angiogenesis have been described. However, in most of these models, only a single stage of the 52 angiogenic cascade is investigated, e.g. proliferation, migration or tube formation. Recently, an all-in-53 one angiogenesis assay has been developed that allows both the qualitative and quantitative 54 assessment of the entire angiogenic cascade [3, 4, 6] . Until now, the majority of in vitro angiogenic 55 models have been developed with human umbilical venous endothelial cells (HUVEC), because these 56 cells are relatively easy to isolate and grow [29] . However, since in vivo angiogenesis mostly proceeds 57 in the microvasculature, it would be more appropriate to investigate in vitro models with 58 microvascular endothelial cells [29] . 59
In the present study, the influence of exogenously administered ANGPT1 and ANGPT2 was 60 investigated in the all-in-one angiogenesis model applied to microvascular endothelial cells derived 61 from the human heart and neonatal foreskin. The growth factors ANGPT1 (CYT-413; Biotrend Chemikalien GmbH, Köln, Germany) and/or ANGPT2 81 (CYT-414; Biotrend Chemikalien GmbH, Köln, Germany) were added to the media at a concentration 82 of 100 ng/ml, as previously determined [28] . In a preliminary study no angiogenic or antiangiogenic 83 effect could be observed of ANGPT1 or ANGPT2 when these were administered at a concentration of 84 50 ng/ml, whereas application of both growth factors at concentrations of 100 or 200 ng/ml led to 85 angiogenic effects (unpublished data). angiopoietins in HCMEC cultures led to a moderate angiogenic response ( Fig. 1 and 2) , in which the 132 cultures did not go beyond stage 3 of angiogenesis in vitro, whereas addition of the angiopoietins in 133 HDMEC cultures led to an angiogenic response ( Fig. 3 and 4) . After 20 days, the HDMEC's formed a 134 network, but this network remained in a two dimensional state. Addition of GM led to higher cell 135 densities in both HCMEC as well as in HDMEC cultures, but no additional effect on the angiogenic 136 process was observed. 
RT-qPCR 150
The RNA quality indicator (RQI) varied between 9.5 and 8.5 for all samples, indicating that RNA 151 degradation during processing was minimal [14] . The comparison of the combined gene expression 152 between the different cell types with the REST software (Qiagen) revealed significant differences in 153 gene expression between these cell types. ANGPT2 mRNA was significantly down-regulated in 154 HCMEC's compared to HDMEC's, by a mean factor of 0.019 (S.E. range is 0.004 -0.098; P-value < 155 0.05) whereas ANGPT1 mRNA was significantly up-regulated in HCMEC's compared to HDMEC's, by a 156 mean factor of 3595.302 (S.E. range is 161.197 -63881.461; P-value < 0.05) (Fig. 5) . No significant 157 difference was found for TIE2 mRNA expression between the two cell types. In contrast, TIE1 mRNA 158 was less abundant in HCMEC's as compared to HDMEC's, by a mean factor of 0.308 (S.E. range is 159 0.085 -1.231; P-value < 0.05) (Fig. 5) . 160
Gene expression was also time dependent in the both cell cultures. Expression of ANGPT2 mRNA in 161 HDMEC's was positively correlated with length of cultivation (P-value = 0.004; R^2 = 0.771). 162
Expression of mRNA for ANGPT1 was not detected in de HDMEC's cells, after 3 and 10 days of 163 culture, but it became expressed after 20 and 40 days of culture (figure 6). TIE2 expression in 164 HCMEC's was negatively correlated with increasing days in culture (P-value = 0.004; R^2 = 0.767), and 165 TIE1 expression was stably expressed in both cultures between days 3 to 20, but after 40 days of 166 culture, it was downregulated in both cultures (Fig. 7) . 167
Discussion: 168
The angiopoietins, i.e. ANGPT1 and ANGPT2 are important angiogenic growth factors. They are 169 crucial for the normal development of the vasculature, but are also implicated in diverse 170 cardiovascular pathologies [33] . The complex interactions between ANGPT1 and ANGPT2, and their 171 exact function are still elusive, and seem to depend on the tissue environment [2] . In the present 172 study, the effect of the angiopoietins was tested in a recently developed in vitro angiogenesis assay, 173 which has previously been established to allow the quantitative assessment of the whole angiogenic 174 cascade, without the use of an external extracellular matrix [3, 6] . 175 ANGPT2 is frequently viewed as an antagonist to the function of ANGPT1 through competitive 176 binding on the TIE2 receptor [26] . However, its function seems to be context dependent, and in 177 certain situations, ANGPT2 has been observed to induce angiogenesis through the activation of TIE2 178 [25] . In the present study, the pro-angiogenic effects of ANGPT2 were similar to those of ANGPT1 179 and to those of the combination of ANGPT1 and ANGPT2, suggesting that ANGPT2 does not act as an 180 antagonist to ANGPT1 in this in vitro setting. Conflicting data exists about the capacity of ANGPT2 to 181 induce TIE2 activation in vitro [22, 32] . The action of the angiopoietins is thought to depend on 182 interactions between TIE2 and TIE1 [18, 19] , and these complex interactions are since long a subject 183 of debate [2, 33] . Recent evidence has revealed that homodimerization and activation of TIE2 is 184 inhibited through the formation of TIE1-TIE2 heterodimers, in which TIE1 might function as an 185 inhibitory co-receptor [27] . ANGPT1 is able to break the association of the TIE2-TIE1 heterodimers, 186 and to induce homodimerization of two TIE2's, resulting in receptor activation. In contrast, ANGPT2 187
is not able to break these heterodimers, and is unable to activate the TIE2 receptor when it is 188 associated with TIE1 [27]. ANGPT2 is able to induce TIE2 activation in HUVEC's with experimentally 189 downregulated TIE1 expression, suggesting that ANGPT2 is able to activate the TIE2 receptor and 190 that it might have similar effect as ANGPT1 in the absence of TIE2-TIE1 heterodimers [19] . However, 191 in endothelial progenitor cells, which both express TIE1 and TIE2, ANGPT2 is able to activate TIE2, 192 because no heterodimers are formed in these cells [19] . In the present study, the expression of The different angiogenic potential of these EC's of distinct origin may also be explained by a 214 differential endogenous mRNA-expression pattern of the endothelial cells. ANGPT1 was highly 215 expressed in the HCMEC, whereas this factor was not expressed in the early stages of angiogenesis of 216 the HDMEC and became only expressed at low levels in the later stages of angiogenesis. In contrast, 217 ANGPT2 was only expressed at basal levels in the HCMEC whilst being highly upregulated in the 218 HDMEC's. This might indicate that the HDMEC are more prone to an angiogenic response due to a 219 higher expression of endogenous ANGPT2, and a low expression of ANGPT1, resulting in an inhibition 220 of TIE2 mediated stabilization of the endothelial cells. A previous study with the same cells has also 221 revealed a significant difference in the expression pattern of mRNA for the VEGF-receptor VEGFR1 222
[6], indicating that endothelial cells of different origin might respond differently to a given stimulus, 223
and that care should be taken when results of angiogenic tests on a specific vascular bed are 224 extrapolated to another vascular bed. 225
In conclusion, the present study revealed that angiopoietins are able to provoke an angiogenic 226 response in microvascular endothelial cell cultures. However, their effect might be highly dependent 227 
